Ajanta Pharma consolidated net profit rises 3.89% in the June 2025 quarter
(28 Jul 2025)

Back
Net profit of Ajanta Pharma rose 3.89% to Rs 255.34 crore in the quarter ended June 2025 as against Rs 245.77 crore during the previous quarter ended June 2024. Sales rose 13.78% to Rs 1302.65 crore in the quarter ended June 2025 as against Rs 1144.92 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales1302.651144.92 14
OPM %26.9728.85 -
PBDT372.42356.09 5
PBT331.13322.12 3
NP255.34245.77 4

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew